Population Pharmacokinetics of Intravenous Methotrexate in Patients with Hematological Malignancies: Utilization of Routine Clinical Monitoring Parameters
Crossref DOI link: https://doi.org/10.1007/s13318-016-0338-1
Published Online: 2016-04-08
Published Print: 2017-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nader, Ahmed
Zahran, Noran
Alshammaa, Aya
Altaweel, Heba
Kassem, Nancy
Wilby, Kyle John
Funding for this research was provided by:
Qatar Foundation (UREP15-019-3-008)
Text and Data Mining valid from 2016-04-08